Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Japanese ophthalmology powerhouse Santen Pharmaceutical said on September 12 that President and CEO Shigeo Taniuchi has offered to resign from the post for “personal reasons.” Executive Vice President Takeshi Ito was promoted to CEO, effective the same day. The personnel…
To read the full story
Related Article
- Shigeo Taniuchi to Become CEO of Santen
March 16, 2020
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





